Sequential administration of dacarbazine and fotemustine in patients with disseminated malignant melanoma -an effective combination with unexpected toxicity, 1992. ,
, Eur. J. Cancer, vol.28, pp.447-450
,
Molecular genetics of human malignant melanoma, Cancer Treat. Res, vol.65, pp.201-255, 1993. ,
Current Protocols in Molecular Biology, 1991. ,
Current Protocols in Molecular Biology, 1991. ,
Current Protocols in Molecular Biology, 1991. ,
Karyotypic evolution in human malignant melanoma, Cancer Genet. Cytogenet, vol.19, pp.113-122, 1986. ,
Nonrandom chromosome changes in malignant melanoma, Cancer Res, vol.43, pp.5010-5016, 1983. ,
Unknotting the complexities of multidrug resistance : the involvement of DNA topoisomerase in drug action and resistance, J. Natl Cancer Inst, vol.81, pp.1683-1685, 1989. ,
Strategies to circumvent multidrug resistance due to Pglycoprotein or to altered DNA topoisomerase Il, Bull. Cancer, vol.77, pp.1131-1141, 1990. ,
Clinical significance of multi drug resistance in human cancer, Anticancer Reasearch, vol.10, pp.1297-1302, 1990. ,
, GenBank. Nucl. Acids Research, vol.21, pp.2963-2965, 1993.
The nude mouse in cancer reasearch, Advances in Cancer Reasearch, vol.44, pp.69-120 ,
Clinical and genetic patterns in dutch FAMM families, Symposium on the third International conference on melanoma, pp.31-34, 1993. ,
Genetie aspects of multidrug resistance. Cancer suppl, vol.70, pp.1799-1809, 1992. ,
Cellular resistance to actinomycin D in Chinese hamster ce11s in vitro : cross resistance radioautographic and cytogenetic studies, Cancer Res, vol.30, pp.117-121, 1970. ,
The role of glutathione-dependent enzymes in drug resistance, Pharmacol. Ther, vol.51, pp.139-154, 1991. ,
Apport d'une nouvelle nitrosourée : la fotémustine, Path. Biol, vol.40, pp.964-968, 1992. ,
Traitement du mélanome malin disséminé, Path. Biol, vol.40, pp.960-963, 1992. ,
Transformation of rat liver epithelial cells with V-H-ras or V-H-raf causes expression of MDRl, glutathione-S-transferase-P and increased resistance to cytotoxic chemicals, Carcinogenesis, vol.9, pp.2329-2332, 1988. ,
Gène de la résistance multidrogue MDRl, Bull. Cancer, vol.76, pp.973-977, 1989. ,
Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs, Journal of the National Cancer Institute, vol.85, pp.632-639, 1993. ,
Use of stock solutions to simplify mRNA quantitation by reverse transcription-PCR assays, PCR Methods and applications, vol.2, p.353, 1993. ,
Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction, Anal. Biochem, vol.162, pp.156-159, 1987. ,
Characterisation and immunological identification of cDNA clones encoding two human DNA topoisomerase II isoenzymes, Proc. Natl Acad. Sei, vol.86, pp.9431-9435, 1989. ,
Systemic chemotherapy for malignant melanoma, World J. Surg, vol.16, pp.277-281, 1992. ,
Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. The New Engl, J. ofMed, vol.327, p.523, 1992. ,
The role of glutathione and Glutathione Transferases in chemical carcinogenesis, Biochem. Mol. Biol, vol.25, pp.47-70, 1990. ,
An Example of the Role of the Animal Model in Investigating New Techniques, Eur. J. Clin. Oncol, vol.25, pp.1511-1512, 1989. ,
Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats, Proc. Natl. Acad. Sei. USA, vol.83, pp.9328-9332, 1986. ,
Cellular and molecular biology of melanoma, Seminars in surgical Oncology, vol.8, pp.353-357, 1992. ,
Cancer : Principles and practice of oncology, Philadelphia: Llppincott, pp.276-300, 1989. ,
Lass of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression, Proc. Natl. Acad. Sei. USA, vol.86, p.4618, 1989. ,
,
, DNA Topo-isomerases from rat liver : physiological variations, vol.11, pp.1059-1075
Disseminated melanoma -Is there a new standard therapy 7 The New Engl, J. of Med, vol.327, pp.560-561, 1992. ,
Expression of the Drosophila type II topoisomerase is developmentally regulated, Biochemistry, vol.27, pp.560-565, 1988. ,
Quantitative or semi-quantitative PCR : reality versus myth, PCR Methods and Applications, vol.2, pp.1-9, 1992. ,
,
A phase II study of dacarbazine and cisplatin in combination with outpatients administred interleukine-2 in metastatic malignant melanoma, Cancer, vol.71, pp.3520-3525, 1993. ,
Nude" a new hair less gene with pleiotropic effects in the mouse, Genet. Res, vol.8, pp.295-301, 1966. ,
Expression of a multidrug-resistance gene in human tumors and tissues, Proc. Natl Acad. Sei. USA, vol.84, pp.265-269, 1987. ,
,
The glutathione S-transferases : patients with pituitary adenomas, Carcinogenesis, vol.14, pp.563-566, 1993. ,
, , 1983.
, Correlation Between Reponse to Chemotherapy of Human Tumors in Patients and in Nude Mice, Cancer, vol.52, pp.1146-1152
,
Expression of a multidrug resistance gene in human cancers, J. Natl Cancer lnst, vol.81, pp.116-124, 1989. ,
Multidrug resistance in human cancer, Critical Rewiews in Oncology/Hematology, vol.12, pp.243-253, 1992. ,
Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem, vol.62, pp.385-427, 1993. ,
Molecular cloning of the CD2 antigen. The T-cell erythrocyte receptor, by a rapid immunoselection procedure, Proc. Natl. Acad. Sei. USA, vol.84, pp.3365-3369, 1983. ,
Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of Topoisomerase II, Cancer Res, vol.48, pp.6404-6410, 1988. ,
Malignant melanoma in different ethnie groups in Israël, Cancer, vol.71, pp.2746-2750, 1993. ,
,
, Natural NK-cell targets in the mouse thymus : characteristics of the sensitive cell population, J. Immunol, vol.123, pp.765-771
,
, Nature, vol.286, p.860, 1980.
Mechanisms of multidrug resistance in cancer treatment, Acta Oncologica, vol.31, pp.205-213, 1992. ,
Natural cell-mediated cytotoxicity in nude mice. In : the nude mouse in experimental and clinical research, cds FOGH J, pp.135-141, 1978. ,
Natural cytotoxicity reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors, 1975. ,
, Distribution ofreactivity and specificity, Int. J. Cancer, vol.16, pp.216-225
,
,
Le mélanome malin cutané en Nouvelle-Calédonie 1973-1991. Etude de 97 observations, Bull. Cancer, vol.80, pp.235-247, 1993. ,
, , 1989.
, Chromosomal localization of human glutathione genes of classes alpha, mu and pi, Hum. Genet, vol.82, pp.338-342
Altered fonction of DNA Topoisomerase as a basis for antineoplastic drug action, pp.65-81, 1989. ,
Pronostic factors in metastatic melanoma, Cancer, vol.71, pp.2995-3005, 1993. ,
Primer-directed enzymatic amplification of DAN with a thermostable DNA polymerase, Science, vol.239, pp.487-491, 1989. ,
,
Glutathione and cellular response of ACNU-resistant rat glioma sublines to drugs and radiation. lnt, J. Cancer, vol.48, pp.861-865, 1991. ,
Clinical detection of multidrug resistance and reversai with chemosensitizing agents, pp.257-269, 1992. ,
, Molecular Cloning, vol.1, 1971.
Malignant melanoma, Annu. Rev. Med, vol.44, pp.335-342, 1993. ,
A simple method for R banding of human chromosomes, showing a pH-dependent connection between R and G bands, Humangenetik, vol.4, pp.55-58 ,
Identification of an anionic form of Glutathione Transferase present in many human tumors and cell lines, Cancer Res, vol.48, pp.527-533, 1988. ,
Chromosome abnormalities and fragile sites in human melanoma, Cancer Genet. Cytogenet, vol.44, pp.61-67, 1990. ,
The reponse to chemotherapy of a variety of human tumour xenografts, Br. J. Cancer, vol.47, pp.1-013, 1983. ,
Proliferation dependance of Topoisomerase II mediated drug action, Biochemistry, vol.25, pp.2248-2256, 1986. ,
Reduction in glutathione content of L-PAM resistant L1210 cell confers drug sensitivity, Biochem. Pharmacol, vol.31, pp.121-124, 1982. ,
Topoisomerase Ila. and Topoisomerase II~ genes : characterization and mapping to human chromosomes 17 and 3, respectively, Cancer Res, vol.52, pp.231-234, 1992. ,
Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors, J. Natl Cancer Inst, vol.81, pp.1732-1735, 1989. ,
Development of a sensitive reverse transcriptase PCR assay, RT-PCR, utilizing rapid cycle times, PCR Methods and Applications, vol.2, pp.137-143, 1992. ,
Characterisation of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum, Cancer Res, vol.47, pp.388-393, 1987. ,
The role of Glutathions S Transferase in anticancer drug resistance, MIHICH E. Drug resistance : mechanisms and reversa!. Rome: John Llbbey CIC, pp.109-119, 1990. ,
Glutathione-S-Transferase and antineoplastic drug resistance, Cancer Bull, vol.41, pp.31-37, 1989. ,
Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6, Science, vol.247, pp.568-571, 1990. ,
Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma, Cancer Res, vol.49, pp.420-423, 1989. ,
Relation of cytogenetic abnormalities and clinical outcome in metastatic melanoma, New Engl. J. Med, vol.322, pp.1508-1513, 1980. ,